Models for oral uptake of nanoparticles in consumer products

Toxicology

Volumn 291, Issue 1-3, 2012, Pages 10-17

  Fröhlich, Eleonore ^a   Roblegg, Eva ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Consumer products; Epithelial barriers; Nanomaterials; Silicon oxide; Silver; Titanium dioxide

Indexed keywords

FOOD ADDITIVE; GOLD NANOPARTICLE; METAL OXIDE; PLATINUM; SILVER NANOPARTICLE; TITANIUM DIOXIDE; TOOTHPASTE; ZINC OXIDE;

CONSUMER; DIET; DIETARY INTAKE; EPITHELIUM CELL; ESOPHAGUS; FOOD INDUSTRY; GASTROINTESTINAL TRACT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; INTESTINE TRANSIT TIME; MEMBRANE TRANSPORT; MOUTH CAVITY; MUCUS; MUCUS SECRETION; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW; SALIVA; SQUAMOUS EPITHELIUM;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; ENVIRONMENTAL EXPOSURE; FOOD; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL MUCOSA; METALS; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; NANOPARTICLES; PERMEABILITY; TOOTHPASTES;

EID: 84155162845     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.004     Document Type: Review

References (117)

1. Ahmadi F., Kurdestany A. The impact of silver nano particles on growth performance. Global Veterinaria 2010, 5:366-370.
2. Ahmadi J. Application of different levels of silver nanoparticles in food on the performance and some blood parameters of broiler chickens. World Appl. Sci. J. 2009, 7:24-27.
3. Ahmadi J., Irani M., Choobchian M. Pathological study of intestine and liver in broiler chickens after treatment with different levels of silver nanoparticles. World Appl. Sci. J. 2009, 7:28-32.
4. Alkhamis K., Salem M., Khanfar M. Determination of the mechanism of uptake of organic vapors by chitosan. Pharm. Dev. Technol. 2009, 14:90-95.
5. Armitage S.A., White M.A., Wilson H.K. The determination of silver in whole blood and its application to biological monitoring of occupationally exposed groups. Ann. Occup. Hyg. 1996, 40:331-338.
6. Atuma C., Strugala V., Allen A., Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G922-G929.
7. Avdeef A., Testa B. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques. Cell. Mol. Life Sci. 2002, 59:1681-1689.
8. Bhaskar K.R., Gong D.H., Bansil R., Pajevic S., Hamilton J.A., Turner B.S., LaMont J.T. Profound increase in viscosity and aggregation of pig gastric mucin at low pH. Am. J. Physiol. 1991, 261:G827-G832.
9. Bihari P., Vippola M., Schultes S., Praetner M., Khandoga A.G., Reichel C.A., Coester C., Tuomi T., Rehberg M., Krombach F. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 2008, 5:14.
10. Bu Q., Yan G., Deng P., Peng F., Lin H., Xu Y., Cao Z., Zhou T., Xue A., Wang Y., Cen X., Zhao Y.L. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2010, 21:125105.
11. Bykov V.L. The tissue and cell defense mechanisms of the oral mucosa. Morfologiia 1996, 110:14-24.
12. Bykov V.L. The functional morphology of the epithelial barrier of the oral mucosa. Stomatologiia (Mosk) 1997, 76:12-17.
13. Carr K.E., Hazzard R.A., Reid S., Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 1996, 13:1205-1209.
14. Cedervall T., Lynch I., Foy M., Berggard T., Donnelly S.C., Cagney G., Linse S., Dawson K.A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 2007, 46:5754-5756.
15. Cha K., Hong H.W., Choi Y.G., Lee M.J., Park J.H., Chae H.K., Ryu G., Myung H. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol. Lett. 2008, 30:1893-1899.
16. Chen E.Y., Garnica M., Wang Y.C., Chen C.S., Chin W.C. Mucin secretion induced by titanium dioxide nanoparticles. PLoS One 2011, 6:e16198.
17. Chen E.Y., Wang Y.C., Chen C.S., Chin W.C. Functionalized positive nanoparticles reduce mucin swelling and dispersion. PLoS One 2010, 5:e15434.
18. Chen Z., Meng H., Xing G., Chen C., Zhao Y., Jia G., Wang T., Yuan H., Ye C., Zhao F., Chai Z., Zhu C., Fang X., Ma B., Wan L. Acute toxicological effects of copper nanoparticles in vivo. Toxicol. Lett. 2006, 163:109-120.
19. Chung T.H., Wu S.H., Yao M., Lu C.W., Lin Y.S., Hung Y., Mou C.Y., Chen Y.C., Huang D.M. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007, 28:2959-2966.
20. Clift M.J., Rothen-Rutishauser B., Brown D.M., Duffin R., Donaldson K., Proudfoot L., Guy K., Stone V. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol. Appl. Pharmacol. 2008, 232:418-427.
21. Collins L.M., Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 1987, 66:1300-1302.
22. Cone R.A. Barrier properties of mucus. Adv. Drug Deliv. Rev. 2009, 61:75-85.
23. Corfield A.P., Wagner S.A., Clamp J.R., Kriaris M.S., Hoskins L.C. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 1992, 60:3971-3978.
24. Coupe A.J., Davis S.S., Wilding I.R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 1991, 8:360-364.
25. Dawson M., Wirtz D., Hanes J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J. Biol. Chem. 2003, 278:50393-50401.
26. des Rieux A., Fievez V., Theate I., Mast J., Preat V., Schneider Y.J. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur. J. Pharm. Sci. 2007, 30:380-391.
27. des Rieux A., Ragnarsson E.G., Gullberg E., Preat V., Schneider Y.J., Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur. J. Pharm. Sci. 2005, 25:455-465.
28. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 1996, 13:1838-1845.
29. Dhar S., Mali V., Bodhankar S., Shiras A., Prasad B.L., Pokharkar V. Biocompatible gellan gum-reduced gold nanoparticles: cellular uptake and subacute oral toxicity studies. J. Appl. Toxicol. 2010, 1:9. [Epub ahead of print]. 10.1002/jat.1595.
30. Diaz del Consuelo I., Falson F., Guy R.H., Jacques Y. Transport of fentanyl through pig buccal and esophageal epithelia in vitro. Influence of concentration and vehicle pH. Pharm. Res. 2005, 22:1525-1529.
31. Doherty G.J., McMahon H.T. Mechanisms of endocytosis. Ann. Rev. Biochem. 2009, 78:857-902.
32. 2 and lactate dehydrogenase. Biol. Trace Elem. Res. 2010, 136:302-313.
33. Eom H.J., Choi J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol. In Vitro 2009, 23:1326-1332.
34. Fröhlich E., Kueznik T., Samberger C., Roblegg E., Wrighton C., Pieber T.R. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. Toxicol. Appl. Pharmacol. 2010, 242:326-332.
35. Gaumet M., Gurny R., Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur. J. Pharm. Sci. 2009, 36:465-473.
36. Geiser M., Rothen-Rutishauser B., Kapp N., Schurch S., Kreyling W., Schulz H., Semmler M., Im Hof V., Heyder J., Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 2005, 113:1555-1560.
37. Gerbert A., Rothkotter H.J., Pabst R. M-cells in peyer's patches of the intestine. Int. Rev. Cytol. 1996, 167:91-159.
38. Gottschalk F., Sonderer T., Scholz R.W., Nowack B. Modeled environmental concentrations of engineered nanomaterials (TiO(2), ZnO, Ag, CNT, Fullerenes) for different regions. Environ. Sci. Technol. 2009, 43:9216-9222.
39. Greulich C., Diendorf J., Simon T., Eggeler G., Epple M., Koller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011, 7:347-354.
40. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Söderholm J.D., Artusson P. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the peyer's patches. J. Pharmacol. Exp. Ther. 2006, 319:632-639.
41. Gullberg E., Leonard M., Karlsson J., Hopkins A., Baryden D., Baird W., Artursson P. Expression of specific markers and particles transport in a new human intestinal M cell model. Biochem. Biophys. Res. Commun. 2000, 279:803-813.
42. Hansen S.F., Michelson E.S., Kamper A., Borling P., Stuer-Lauridsen F., Baun A. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 2008, 17:438-447.
43. Harris A., Bali R. On the formation and extent of uptake of silver nanoparticles by live plants. J. Nanopart. Res. 2008, 10:691-695.
44. Harris D., Robinson J.R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992, 81:1-10.
45. Harush-Frenkel O., Rozentur E., Benita S., Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 2008, 9:435-443.
46. Hazzard R.A., Hodges G.M., Scott J.D., McGuinness C.B., Carr K.E. Early intestinal microparticle uptake in the rat. J. Anat. 1996, 189(Pt 2):265-271.
47. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009, 5:2722-2729.
48. Heister E., Lamprecht C., Neves V., Tilmaciu C., Datas L., Flahaut E., Soula B., Hinterdorfer P., Coley H.M., Silva S.R., McFadden J. Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. ACS Nano 2010, 4:2615-2626.
49. Hillery A.M., Jani P.U., Florence A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60nm polystyrene particles. J. Drug Target. 1994, 2:151-156.
50. Hillyer J.F., Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 2001, 90:1927-1936.
51. Horter D., Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2001, 46:75-87.
52. Hoskins L.C., Boulding E.T. Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. J. Clin. Invest. 1981, 67:163-172.
53. Huang D.M., Hung Y., Ko B.S., Hsu S.C., Chen W.H., Chien C.L., Tsai C.P., Kuo C.T., Kang J.C., Yang C.S., Mou C.Y., Chen Y.C. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J. 2005, 19:2014-2016.
54. Huh C.H., Bhutani M.S., Farfan E.B., Bolch W.E. Individual variations in mucosa and total wall thickness in the stomach and rectum assessed via endoscopic ultrasound. Physiol. Meas. 2003, 24:N15-N22.
55. Jang M.H., Kweon M.N., Iwatani K., Yamamoto M., Terahara C., Sasakawa C., Suzuki T., Nochi T., Yokota Y., Rennert P.D., Hiroi T., Tamagawa H., Irijima H., Kunisawa J., Yuki Y., Kiyono H. Intestinale villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6110-6115.
56. Jani P., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 1990, 42:821-826.
57. Jani P., McCarthy D., Florence A. Titanium dioxide (rutile) particles uptake from the rat GI tract and translocation to the systemic organs after oral administration. Int. J. Pharm. 1994, 105:157-168.
58. Jeong G.N., Jo U.B., Ryu H.Y., Kim Y.S., Song K.S., Yu I.J. Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague-Dawley rats. Arch. Toxicol. 2010, 84:63-69.
59. Jiang X., Rocker C., Hafner M., Brandholt S., Dorlich R.M., Nienhaus G.U. Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. ACS Nano 2010, 4:6787-6797.
60. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 1995, 16:351-380.
61. Katao K., Honma R., Kato S., Watanabe S., Imai J. Influence of platinum nanoparticles orally administered to rats evaluated by systemic gene expression profiling. Exp. Anim. 2011, 60:33-45.
62. Kerneis S., Bogdonona A., Kraehenbuhl J.P., Pringault E. Conversion by Peyer's patches lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997, 277:949-952.
63. Kim W.Y., Kim J., Park J.D., Ryu H.Y., Yu I.J. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J. Toxicol. Environ. Health 2009, 72:1279-1284.
64. Kim Y.S., Kim J.S., Cho H.S., Rha D.S., Kim J.M., Park J.D., Choi B.S., Lim R., Chang H.K., Chung Y.H., Kwon I.H., Jeong J., Han B.S., Yu I.J. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2008, 20:575-583.
65. Kim Y.S., Song M.Y., Park J.D., Song K.S., Ryu H.R., Chung Y.H., Chang H.K., Lee J.H., Oh K.H., Kelman B.J., Hwang I.K., Yu I.J. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 2010, 7:20.
66. Knowles M.R., Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 2002, 109:571-577.
67. Koeneman B.A., Zhang Y., Westerhoff P., Chen Y., Crittenden J.C., Capco D.G. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol. Toxicol. 2010, 26:225-238.
68. Lagerlof F., Dawes C. The volume of saliva in the mouth before and after swallowing. J. Dent. Res. 1984, 63:618-621.
69. Lai S.K.a., O'Hanlon D.E.b., Harrold S.b., Man S.T.a., Wang Y.-Y.d., Cone R.b., Hanes J.a.c.d.e. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Nat. Acad. Sci. U.S.A. 2007, 104:1482-1487.
70. Lamb J.G., Hathaway L.B., Munger M.A., Raucy J.L., Franklin M.R. Nanosilver particle effects on drug metabolism in vitro. Drug Metab. Dispos. 2010, 38:2246-2251.
71. Lamprecht A., Schafer U., Lehr C.M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001, 18:788-793.
72. Lankveld D.P., Oomen A.G., Krystek P., Neigh A., Troost-de Jong A., Noorlander C.W., Van Eijkeren J.C., Geertsma R.E., De Jong W.H. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010, 31:8350-8361.
73. Leonhard F., Collnot E.M., Lehr C.M. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in-vitro. Mol. Pharm. 2010, 7:2103-2119.
74. Loeschner K., Hadrup N., Qvortrup K., Larsen A., Gao X., Vogel U., Mortensen A., Lam H.R., Larsen E.H. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 2011, 8:18-20.
75. Lomer M.C., Hutchinson C., Volkert S., Greenfield S.M., Catterall A., Thompson R.P., Powell J.J. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br. J. Nutr. 2004, 92:947-955.
76. Lomer M.C., Thompson R.P., Commisso J., Keen C.L., Powell J.J. Determination of titanium dioxide in foods using inductively coupled plasma optical emission spectrometry. Analyst 2000, 125:2339-2343.
77. Long J.D., Orlando R.C. Esophageal submucosal glands: structure and function. Am. J. Gastroenterol. 1999, 94:2818-2824.
78. Lynch I., Salvati A., Dawson K.A. Protein-nanoparticle interactions: what does the cell see?. Nat. Nanotechnol. 2009, 4:546-547.
79. Matsuo K., Ota H., Akamatsu T., Sugiyama A., Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997, 40:782-789.
80. Mayer A., Vadon M., Rinner B., Novak A., Wintersteiger R., Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology 2009, 258:139-147.
81. McGill S.L., Smyth H.D. Disruption of the mucus barrier by topically applied exogenous particles. Mol. Pharm. 2010, 7:2280-2288.
82. Meng H., Chen Z., Xing G., Yuan H., Chen C., Zhao F., Zhang C., Zhao Y. Ultrahigh reactivity provokes nanotoxicity: explanation of oral toxicity of nano-copper particles. Toxicol. Lett. 2007, 175:102-110.
83. Navarro E., Piccapietra F., Wagner B., Marconi F., Kaegi R., Odzak N., Sigg L., Behra R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 2008, 42:8959-8964.
84. Olmsted S.S., Padgett J.L., Yudin A.I., Whaley K.J., Moench T.R., Cone R.A. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 2001, 81:1930-1937.
85. Pan J., Wang W. Influences of dissolved and colloidal organic carbon on the uptake of Ag, Cd, and Cr by marine mussel Perna viridis. Environ. Pollut. 2004, 129:467-477.
86. Panacek A., Prucek R., Safarova D., Dittrich M., Richtrova J., Benickova K., Zboril R., Kvitek L. Acute and chronic toxicity effects of silver nanoparticles (NPs) on Drosophila melanogaster. Environ. Sci. Technol. 2011, 45:4974-4979.
87. Park E., Kim H., Kim Y., Choi K. Repeated-dose toxicity attributed to aluminum nanoparticles following 28-day oral administration particularly on gene expression in mouse brain. Toxicol. Environ. Chem. 2011, 93:110-119.
88. Park E.J., Bae E., Yi J., Kim Y.S., Choi K., Lee S.H., Yoon J., Lee B.C., Park K. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 2010, 30:162-168.
89. Pietzonka P., Rothen-Rutishauser B., Langguth P., Wunderli-Allenspach H., Walter E., Merkle H.P. Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake. Pharm. Res. 2002, 19:595-601.
90. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimmun. 2010, 34:J226-J233.
91. Ragnarsson E.G., Schoultz I., Gullberg E., Carlsson A.H., Tafazoli F., Lerm M., Magnusson K.E., Soderholm J.D., Artursson P. Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Lab. Invest. 2008, 88:1215-1226.
92. Roblegg E., Fröhlich E., Meindl C., Teubl B., Zaversky M., Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 2011, 1-15. 10.3109/17435390.2011.580863.
93. Ruponen M., Honkakoski P., Tammi M., Urtt A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J. Gene Med. 2004, 6:405-414.
94. Sager T.M., Porter D., Robinson V., Lindsley W.G., Schwegler-Berry D.E., Castranova V. An improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 2007, 1:118-129.
95. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J. Control. Release 2010, 145:182-195.
96. Saltzman W.M., Radomsky M.L., Whaley K.J., Cone R.A. Antibody diffusion in human cervical mucus. Biophys. J. 1994, 66:508-515.
97. Schreiber S., Scheid P. Gastric mucus of the guinea pig: proton carrier and diffusion barrier. Am. J. Physiol. 1997, 272:G63-G70.
98. Scown T.M., van Aerle R., Johnston B.D., Cumberland S., Lead J.R., Owen R., Tyler C.R. High doses of intravenously administered titanium dioxide nanoparticles accumulate in the kidneys of rainbow trout but with no observable impairment of renal function. Toxicol. Sci. 2009, 109:372-380.
99. 2: role of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol. 2007, 222:141-151.
100. Squier C.A., Kremer M.J. Biology of Oral Mucosa and Esophagus 2001, Oxford Journals: JNCI Monographs, pp. 7-15.
101. Stoeger T., Reinhard C., Takenaka S., Schroeppel A., Karg E., Ritter B., Heyder J., Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ. Health Perspect. 2006, 114:328-333.
102. Sudhakar Y., Kuotsu K., Bandyopadhyay A.K. Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs. J. Control. Release 2006, 114:15-40.
103. Sun W., Fang N., Trewyn B.G., Tsunoda M., Slowing I.I., Lin V.S., Yeung E.S. Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy. Anal. Bioanal. Chem. 2008, 391:2119-2125.
104. Szentkuri L. Light microscopic observation on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J. Control. Release 1997, 46:233-242.
105. Takizawa H., Ohtoshi T., Ohta K., Hirohata S., Yamaguchi M., Suzuki N., Ueda T., Ishii A., Shindoh G., Oka T., et al. Interleukin 6/B cell stimulatory factor-II is expressed and released by normal and transformed human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 1992, 187:596-602.
106. Takubo K. Pathology of the Esophageus: An Atlas and Textbook 2009, Springer, Tokyo, Berlin, Heidelberg.
107. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69:8784-8789.
108. Wang B., Feng W.Y., Wang M., Wang T., Gu Y., Zhu M., Ouyang H., Shi J., Zhang F., Zhao Y. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J. Nanopart. Res. 2008, 10:263-276.
109. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
110. Wang J.J., Sanderson B.J., Wang H. Cyto- and genotoxicity of ultrafine TiO(2) particles in cultured human lymphoblastoid cells. Mutat. Res. 2007, 628:99-106.
111. Wang Z., Tiruppathi C., Minshall R.D., Malik A.B. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 2009, 3:4110-4116.
112. 2 particles as a component of nanoparticle risk management. Toxicol. Lett. 2007, 171:99-110.
113. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
114. Yacobi N.R., Demaio L., Xie J., Hamm-Alvarez S.F., Borok Z., Kim K.J., Crandall E.D. Polystyrene nanoparticle trafficking across alveolar epithelium. Nanomed.: Nanotechnol. Biol. Med. 2008, 4:139-145.
115. Zhang R., Niu Y., Li Y., Zhao C., Song B., Zhou Y. Acute toxicity study of the interaction between titanium dioxide nanoparticles and lead acetate in mice. Environ. Toxicol. Pharmacol. 2010, 30:52-60.
116. Zhang X.D., Wu H.Y., Wu D., Wang Y.Y., Chang J.H., Zhai Z.B., Meng A.M., Liu P.X., Zhang L.A., Fan F.Y. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed. 2010, 5:771-781.
117. Zhu X., Zhu L., Chen Y., Tian S. Acute toxicities of six manufactured nanomaterial suspensions to Daphnia magna. J. Nanopart. Res. 2009, 11:65-75.